(OTCQB: FRLF)
Ludlow Research Upgrades
Opinion on OTCQB:FRLF
Raises Price Target from .10
to .25 cents
Based on New Chairman and Hempology
Launch
Freedom Leaf, Inc. (OTCQB: FRLF), "The Marijuana Legalization
Company," announced a research report on the company is now
available for review.
Report Highlights
Pending Launch of Hempology Product Line
- Penetration into Latin America Market
- Upcoming Acquisition in Spain of Green Market Europe, S.
L.
- NuAxon CO2 Extractor Sales
- Appointment of Mr. Pelosi, Jr. as Chairman of the Board
- Improved Revenue and Compliance Outlook
In the report, Ludlow Research made note of FRLF pending launch
of their Hempology consumer line, appointment of Mr. Pelosi Jr. as
the new Chairman of the Board of Directors, and potential expansion
into Latin American cannabis market through with the recent
acquisition of LaMarihuana.com
Summary
Based on the appointment of Mr. Pelosi as the new Chairman of
the company, and their ongoing operations such as Hempology, Green
Market Europe S. L., NuAxon CO2 Extractor sales, and penetration
into the Latin American market, along with expectation of the
projected sales through June, 2017, Ludlow Research has upgraded
its research opinion on Freedom Leaf, Inc. (OTCQB: FRLF).
To download the full report, risks, and disclosures on this
company please visit http://www.ludlowresearch.com/reports.html